group compared with the Control group at 12 weeks (P .05). A positive correlation was identified in the Treatment group between increased failure loads at 12 weeks and the following parameters: tendonbone integration, new bone formation, and collagen type III. No statistically significant differences in biomechanical properties were identified between Treatment and Control Groups (P > .05). Conclusions: Use of a vented anchor attached to a bioresorbable interpositional scaffold composed of aligned PLGA microfibers improves the histologic properties of rotator cuff repairs in a sheep model. Improved histology was correlated with improved final construct strength at the 12-week time point. Rotator cuff tendon tears are common and represent the most common shoulder injury for patients requiring surgical treatment. An estimated 450,000 rotator cuff repairs are performed in the United States per year. 42 With an aging population (>60 years of age) and increasing frequency of tearing, the need for repair is expected to continue to grow. 6, 16, 19, 45 Patients affected by a rotator cuff tear often demonstrate limited shoulder mobility, reduced strength, and pain. Successful rotator cuff repair can be challenging, especially in chronic situations where poor tendon and bone are present. Numerous factors are associated with impaired healing, such as poor tendon quality and vascularity, muscle atrophy, and fatty infiltration. 3, 7, [11] [12] [13] 26, 47 Additional patient factors such as systemic medical morbidities, including diabetes and tobacco use, can result in high rates of repair failures, with structural failure ranging from 30% to as high as 94%. 1, 11, 13 The goal of a rotator cuff repair is to form an enthesis (or a stable mechanical attachment of the muscle-tendon unit to the bony attachment site on the proximal humerus) that mimics the mechanical function of the native tendon-to-bone interface. Traditional techniques have mainly focused on improving the mechanical attachment of the tendon-bone interface, with less emphasis on improved biological healing; however, biological healing is critical to achieve a durable union at the tendon-bone interface.
Various techniques have been employed to improve interface healing, including bone marrow venting; cellular therapies (mesenchymal stem cells); and xenograft, allograft, or acellular scaffolds. 27, 29, 32, 36, 41 Bone marrow vents have shown promise in improving the bone-tissue interface healing of many soft tissue injuries by allowing autologous marrow-derived cells to reach the repair site. 9, 37 Bone marrow venting is a comparatively expeditious surgical procedure, has no issue of cellular incompatibility, and may be accomplished through vented tissue anchors or through separate bone puncture holes. 9, 46 Potential problems with bone puncture holes for bone marrow venting is that it can weaken the bone around the venting holes, possibly leading to inadequate anchor fixation in the bone. 37 Scaffolds or ''patches'' have also shown value for augmenting torn tissue and promoting tissue thickening. 32, 41 Tissue thickening has been demonstrated to have a beneficial effect on the inherent mechanical strength of the repair. 38, 41 Most scaffolds are placed on top of the tendon (ie, onlay), not as an interposition between the tendon and the bone, and are primarily designed to add initial mechanical strength and surface area to the repair site, potentially reducing and preventing tendon retear and retraction from the footprint. 14, 32 Recently, interest in interposition (ie, inlaydbetween the tendon and bone at the footprint) patches has increased as it is believed to not only improve the strength of the repair site, similar to onlay scaffolds but also lead to increased bone-tendon integration via increased cellular activity. The mechanism of action of interposition patches is thought to be conveyed by increasing the biomechanical properties of the repair via the cellular response to the scaffold. 36 Because of the potential benefits observed with these surgical techniques (ie, bone venting and interposition scaffold augmentation), it was hypothesized that a combination of a marrow venting anchor, with an attached interposition scaffold, may be advantageous to rotator cuff repair healing. Therefore, the purpose of this study was to compare the healing rates, biomechanical strength, and histologic properties of rotator cuff repairs performed using a vented anchor attached to a bioresorbable interpositional scaffold composed of aligned PLGA (poly(L-lactide-coglycolide)) microfibers to repairs performed using standard suture anchors. A previously investigated sheep rotator cuff model from our research group was used as the animal model. 14, 17, 18, [31] [32] [33] [34] [35] 40, 41 
Materials and methods
Vented suture anchor with PLGA scaffold
The suture anchor with incorporated PLGA scaffold is composed of 2 components: the anchor construct and the scaffold construct, which is integrated into the anchor construct (BioWick SureLock W Suture Anchor, Zimmer-Biomet, Warsaw, IN). The suture anchor implant is an all-suture anchor construct with braided ultrahighmolecular-weight polyethylene suture fibers, and a polyether ether ketone anchor component that serves to house and protect the scaffold and suture components. The scaffold component is a porous, aligned fiber matrix composed of 1-mm-diameter PLGA fibers produced using electrospinning techniques. The dimensions of the scaffold were 8 mm Â 8 mm Â 420 mm (height Â width Â thickness). We hypothesized that the porous nature of the scaffold allows for the essential for cell nutrition, proliferation, and migration during the healing process, permitting infiltration and ingrowth of fibroblasts. Additionally, the pores and aligned fibers should assist in guiding new fibroblast orientation, enabling effective release of biofactors such as proteins, genes, or cells. 20 The PLGA scaffold is manufactured using standard electrospinning fabrication techniques, a process used to make small-diameter fibers using a high electric potential to draw charged polymer solutions to fiber sizes ranging from nanometers to micrometers, depending on the desired application.
Sample size calculation
A power analysis was performed using pilot biomechanical stiffness data (unpublished) examining acute rotator cuff tendon repairs in an ovine model. Two-sample t-test power calculation indicated that n ¼ 7.04 (where d ¼ 6.48, SD ¼ 3.06, bilevel ¼ 0.01, power ¼ 0.8; alternative ¼ 2-sided) were needed per group to achieve statistical fidelity of post hoc analysis.
Animal procedures
Fifty-six (n ¼ 56) skeletally mature female Columbia Cross sheep (ovis aries) (65-115 kg) were randomly assigned to treatment groups (ie, new anchor-PLGA scaffold device ''Treatment'' or predicate device ''Control'') and survival times of either 7 or 12 weeks. The sheep infraspinatus tendon acute transection/repair model was used as previous studies have demonstrated that it is a good analog for the human supraspinatus tendon. 14, 17, 18, [31] [32] [33] [34] [35] 40, 41 Using an open approach, the infraspinatus tendon was sharply detached from the humeral footprint followed by removal of any remaining soft tissue from the footprint by a bone burr. Repair or reattachment of the transected tendon was immediately performed using a total of two 2.7-mm suture anchors (BioWick SureLock W Suture Anchor; Zimmer-Biomet, Warsaw, IN, USA) with a PLGA scaffold (ie, Treatment group) ( Fig. 1 ) or without a PLGA scaffold (Control group) (SureLock All-Suture Anchor; Zimmer-Biomet) and two 2.2-mm suture anchors (SureLock All-Suture Anchor) in a repair construct as described by Lorbach et al 22 using a modified double-row technique. During implantation, the anchor with the integrated PLGA scaffold was oriented laterally such that the scaffold lay on the humeral footprint (ie, inlay position) aligned with the desired direction of the healing tendon fibers prior to reattachment of the infraspinatus tendon. Following reattachment of the infraspinatus tendon, the acromial head of the deltoid muscle was returned to its more cranial position and the deltoid fascia and subcutaneous tissues were closed using a simple continuous suture pattern, and the skin was routinely closed with stainless steel staples. Following recovery, the sheep could move and eat ad libitum for the entirety of the study period. At 7 or 12 weeks, a total of 28 sheep were humanely euthanized with an overdose of barbiturate. Once euthanized, the infraspinatus muscle was isolated and detached from the scapula and the proximal one-third of the humerus was harvested. A total of 13 contralateral untreated shoulders were also randomly collected from sheep to serve as time zero baseline biomechanical and histologic samples.
Harvested humerus-infraspinatus constructs underwent fine dissection to remove any extraneous soft tissues, isolating the tendon from the infraspinatus muscle belly. Repair sutures were left intact following fine dissection. Sixteen (n ¼ 16) samples were allocated for biomechanical testing (n ¼ 8 Treatment and n ¼ 8 Control samples) and 12 (n ¼ 12) samples were allocated for histologic analysis (n ¼ 6 Treatment, and n ¼ 6 Control samples) for each timepoint. Those performing post-euthanization analyses were blinded to treatment groups and euthanizing timepoints until final statistical analyses were performed.
Destructive biomechanical testing
Samples allocated to biomechanical testing underwent crosssectional area (CSA; mm 2 ) measurements of each infraspinatus tendon using an area micrometer (0.0245-mm 2 resolution). To ensure repeatability across samples, area measurements were taken while a 0.12-MPa pressure was applied parallel to the cross section of the tendon without application of axial load to the tendon. 25 Measurements of cross-sectional area were performed at multiple locations (n ¼ 3) along the tendon (distal, middle, and proximal to the humeral attachment of the tendon), and the geometric mean was calculated as the representative CSA. CSA measurements were used to transform structural properties into material properties by normalizing for cross-sectional area thickening in the healing tendon ( machine (MiniBionix 858; MTS Systems, Eden Prairie, MN, USA) using specially designed fixtures (Fig. 2 ). 32 An upper fixture grip attached to the MTS machine's actuator was used to clamp onto the infraspinatus tendon with a brass grip. Solid carbon dioxide was laid around the brass clamp to convert it into a cryoclamp, lowering the temperature to at least -10 C for biomechanical testing. 32 Destructive biomechanical testing included 2 phases: (first) preconditioning and (second) ramp to failure. Ramp to failure was a destructive test and was performed as the last test in the evaluation sequence. To minimize the viscoelastic effects on the measured biomechanical response, 10 cyclic tensile loads ranging between 0 and 2% strain were applied for the purpose of preconditioning the tendon. The preconditioning phase was preceded by a 2-minute preload phase. A static preload of 10 N was applied to all specimens for 2 minutes or until the specimen was fully relaxed. The sample's reference gauge length was measured as the tendon's distance (mm) from the bottom of the cryoclamp's grip to the tendon's insertion into the humerus following the 10-N preload. All ramp to failure loads imparted on the samples were applied quasi-statically (100 mm/min) and aligned collinear to the physiologic loading direction of the tendon. Structural properties representing the biomechanical behavior of the bone-tendon construct and material properties representing the biomechanical behavior at the tissue level were calculated. Force (N) and displacement (mm) data were collected at 100 Hz and used to characterize structural properties of the tendon-bone construct and included ultimate load and stiffness. Material properties were calculated from structural measurements by normalization to cross-sectional area (mm 2 ) or to the initial gauge length (mm) of the sample and included ultimate stress and elastic modulus.
Histologic analysis
Samples (humeral-infraspinatus constructs) allocated to histologic process were fixed in 10% neutral-buffered formalin (!7 days). Samples were bisected through the infraspinatus and humeral attachment sites creating a 1-cm-thick slab of tissue encompassing the bone-tendon repair site (ie, the ''footprint''). Samples underwent a standard decalcification process with 8% formic acid, followed by paraffin embedding. Two (n ¼ 2) regions of interest, separated by 2000 mm, were examined across the footprint to determine the average histopathologic response at the repair site. Eight serial slide sections (5-mm-thick) were cut on a rotary microtome from the region of interest, with 2 (n ¼ 2) slides from each region of interest being stained with (1) hematoxylin and eosin (H&E), (2) picrosirius red, (3) safranin O/fast green, or (4) unstained for immunohistochemistry collagen I and III analyses. Slides were evaluated by a board-certified veterinary pathologist using a modified ISO-1099/6 scoring rubric for 10 metrics, specifically:
1. Inflammation (0-5 score; 0 ¼ no inflammation and 5 ¼ severe inflammation) 2. Fibroblast count (n) 3. Tendon-bone repair distance (mm). For this measurement, the entire distance of the potential humeral insertion surface for the repaired infraspinatus tendon was measured. Landmarks used included the infraspinatus bursa on one end and the end of the humerus bone on the slide on the other end. Picrosirius red-stained slides were used to generate these data. 4. Movin' tendinopathy (0-3 score; 0 ¼ normal and 3 ¼ markedly abnormal). Movin' tendinopathy was a cumulative scoring of the tendon's fiber structure, fiber arrangement, rounding of nuclei, regional variation in cellularity, increased vascularity, and decreased collagen stainability, with each constituent being scored on a 3-point scale and then averaged across a single sample. 29 5. Area of new fibrocartilage (mm 2 ) 6. Percentage tendon-bone integration (%) 7. Percentage perpendicular oriented fibers (%) 8. Collagen I content (0-10 score; 0 ¼ no indication and 10 ¼ strong (þ4) signal) 9. Collagen III content (0-10 score; 0 ¼ no indication and 10 ¼ strong (þ4) signal)
New bone formation at tendon-bone interface (mm 2 )
Fibroblasts were counted in 4Â to 40Â objective fields from H&E sections within 8 mm of the PLGA scaffold when present or within 10 mm of bone-tendon interface when the PLGA scaffold was absent.
Statistical analysis
Statistical significance in the biomechanical and histopathologic output parameters between groups and across time points was performed using a standard 2-way analysis of variance for multiple comparisons, where P values less than .05 were considered statistically significant (Minitab, Inc, State College, PA, USA). Untreated data were not included in the statistical analyses; however, the data are presented as a measure of baseline values. An analysis comparing the histopathology and biomechanical results was performed using Pearson correlation analyses. Within a Pearson product-moment correlation, the pair(s) of variables with positive correlation coefficients and P values <.05 tend to increase together. For the pairs with negative correlation coefficients and P values <.05, one variable tends to decrease whereas the other increases. For pairs with P values >.05, there is no significant relationship between the 2 variables.
Results
All sheep tolerated the surgery well and without complication. A single sheep had mild signs of lameness in the treated limb at 10 days postoperation that resolved within 3 days of nonsteroidal anti-inflammatory drug therapy. No other clinical signs of postoperative pain, infection, or incision dehiscence were noted throughout the entirety of the study period.
Data figures are shown in box and whisker plot format. The ''box'' is bounded by the first and third quartiles; the ''whiskers'' represent the maximum/minimum values within the data set, and the median data bar is highlighted. Statistically significant differences have been highlighted; means that do not share a letter are significantly different.
Histologic results
Histopathology did not indicate any abnormal or adverse reaction or immune response in either surgical group. Qualitatively, tendon repair progressed in an expected fashion from 7 to 12 weeks in both groups. Inflammation scores for the Treatment group at both 7 and 12 weeks were modestly reduced compared to the Control group's ( Fig. 3,  I) . Minimal to mild chronic inflammation and perivascular inflammation was present in both Treatment and Control groups at both 7 and 12 weeks.
As expected, all Treatment and Control fibroblast counts were significantly increased compared to untreated controls, and sum fibroblast counts subsided over time in both groups (Fig. 3, II) .
Tendon-bone repair distance was a measurement of the entire distance of the potential humeral insertion surface for the repaired infraspinatus tendon from picrosirius red sections. The tendon-bone repair distance was significantly greater for the 12-week Treatment group compared with the Control group at 12 weeks, and the Treatment and Control groups at 7-weeks ( Fig. 3, III) .
Movin' tendinopathy scores were generated from evaluation of H&E and picrosirius red sections on a scale from 0-3 for fiber structure, fiber arrangement, rounding of nuclei, regional variations of cellularity, increased vascularity, and decreased collagen stainability. No significant differences were noted between the Treatment and Control groups within either euthanizing time point based on Movin' total sum scores. Movin' scores significantly subsided over time in both groups from 7 to 12 weeks (Fig. 3,  IV) .
Areas of safranin O-positive metachromatic tissue ( Fig. 4 ) that were consistent with fibrocartilage were measured at the infraspinatus tendon-bone interface in mm 2 . No significant differences in area of new fibrocartilage at the tendon-bone interface was noted between or within groups at either time points (Fig. 3, V) .
Percentage tendon-bone integration with any tissue was calculated by dividing the total tendon-bone integration distance (mm) by the total tendon-bone repair distance (mm). Percentage tendon-bone integration was significantly increased in the Treatment group compared to the Control group at 12 weeks (Fig. 3, VI) .
The percentage of tendon-bone integration distance (with respect to any tissue type) occupied by perpendicular fibers was calculated by dividing the distance (mm) fibers were attached to the bone perpendicularly (AE10 ) by the tendon-bone integration distance (mm). Percentage tendonbone integration with perpendicular fibers were significantly increased in the Treatment group compared to the Control group at 12 weeks (Fig. 3, VII) .
Collagen I and III content was scored on a scale from 0-10. Collagen I scores were comparable and stable across the 7-and 12-week time points in the Treatment and Control groups (Fig. 3, VIII) . Collagen III scores ''near'' the PLGA in the Treatment group at 7 and 12 weeks were modestly increased compared with their respective 7-and 12-week controls at the tendon-bone interface (Fig. 3, IX) . In addition, there was a statistically significant increase in collagen type III deposition in the Treatment group as compared to the Control group at 12 weeks (Fig. 3, IX) .
Additionally, the Treatment group had a significant increase in new bone formation at the tendon-bone interface compared with the Control group at 12 weeks (Fig. 3, X) .
For completeness, the untreated samples demonstrated significant reductions in all histopathologic parameters compared with either the Treatment or Control groups at either the 7-or 12-week time points ( Fig. 3 ; P .05 for all comparisons [not shown]).
Biomechanical results
No grossly abnormal pathologies or abnormal tissue reactions were noted at the time of dissection. No experimental issues were noted; all biomechanical tests were run to completion.
There were no significant differences noted in CSAs of the infraspinatus tendons across groups at 7 or 12 weeks (P > .05). No significant differences were noted between the Treatment and Control groups within the 7-week or 12week time points with regards to ultimate failure load (N) (P ! .55), construct stiffness (N-m) (P ! .70), ultimate failure stress (MPa) (P ! .93), or elastic modulus (MPa) (P ! .56) (Fig. 5 ). However, significant differences across time points (ie, 7 weeks vs. 12 weeks) were observed for all biomechanical output parameters (Fig. 5 ). For all biomechanical output parameters, the data indicated statistically significant increases for both surgical groups at the 12-week time point as compared to both groups at the 7-week time point (Fig. 5) . The biomechanical responses of the untreated samples demonstrated increased responses in all measured parameters as compared to both surgical groups at both time points (Fig. 5) .
The Pearson correlation analyses between the histopathology and biomechanical results showed a statistically significant, positive, correlation in the Treatment group between increased failure loads at 12 weeks and the following parameters: tendon-bone integration (R 2 ¼ 0.83, P value ¼ .02), and collagen type III (R 2 ¼ 0.85, P value ¼ .01).
Discussion
This study successfully evaluated a new commercially available, FDA-approved PLGA scaffold device that is incorporated into a vented suture anchor implant for rotator cuff repair in sheep. To our knowledge, this is the first vented suture anchor with an engineered interpositional scaffold for rotator cuff repair. The devices were easy to implant and required no additional steps from the traditional repair technique. Additionally, the devices used in this study could have been implanted using either open surgical or arthroscopic techniques. The data indicated that there were no persistent test article-related toxicologically relevant histopathologic findings relative to the control devices.
The results suggest that the PLGA scaffold has a positive biomimetic effect on the healing quality of infraspinatus tendon to bone following an acute transection and reattachment in a sheep model. Statistical improvements in tendon-bone distance, percentage tendon-bone integration, and percentage tendon-bone integration distance suggest that the PLGA scaffold has a measurable, positive effect on the histopathologic quality of tendon repair. Because both anchors were vented, it is likely that the PLGA scaffold is responsible for improved healing parameters. In addition, because both anchors were vented, this study design was unable to explicitly assess the effect the anchor's vent had on the healing rate. The microfibers of the aligned PLGA scaffold are intended to mimic the extracellular matrix (collagen) of the native rotator cuff tendon. It has been shown that randomly oriented fibers result in more random fibroblast orientation. 10 Therefore, we believe that the fiber alignment of the PLGA scaffold is likely to play a role in the outcomes noted in this study. Furthermore, nonsignificant differences in inflammation and Movin' tendinopathy scores suggest that the addition of the PLGA scaffold has no negative affect on tendon healing.
The ultimate failure loads reported within this study were significantly greater than previously published results using the same acute transection ovine model. Work by Hee et al 14 reported ultimate failure loads of 910.4 AE 156.1 N for suture-only controls, compared with the ultimate failure loads of 1758 AE 750 N found in this study using equivalent biomechanical testing protocols. The main difference between this study and the work by Hee et al is the difference in suture patterns (ie, bridging technique with bone anchors vs. a modified Mason-Allen with bone tunnels, respectively) and the vented anchor design. These data, perhaps in absolute terms, may help corroborate the data presented by others demonstrating the significant effect that acute suture purchase (ie, technique) has on the ultimate strength of the repair 4, 21, 39, 43 and the importance of allowing cellular constituents to reach the repair site.
The sheep acute rotator cuff model is well established and is considered an acceptable model for device testing because of anatomical similarities to humans. 15, 28, 44 Because of the similarities (ie, anatomical features, in vivo biomechanical loading, bone composition and structure, etc) between humans and sheep, we believe that it is acceptable to conjecture that increased biomechanical and histopathologic results between treatment groups detected within this study in the in vivo ovine model would correspond to the increases in repair results observed between treatment groups in human subjects. However, the ovine model is not without limitations. 29, 32, 40 Most notably, the inability to limit weight bearing in a quadrupedal animal can lead to gap formation at the tendon-bone interface. Recently, human studies have shown similar gap formations to occur when repairs to the RTC are loaded acutely. 24 Also, because both implants had a vented design, the data were incapable of clarifying if the anchor's venting was explicitly advantageous. However, the Figure 4 Untreated, control, and treated infraspinatus tendon repair sites at 7 and 12 weeks: these images show the tissue integration at the tendonbone interface. Black brackets denote areas where the repair tissue is not well integrated with the bone. Safranin O stain; 40Â magnification.
data did indicate that the PGLA scaffold in conjunction with a vented anchor had significant positive effects on the healing. Lastly, this study used an acute repair model, whereas rotator cuff tears in people are often chronic and repair occurs after chronic changes have occurred to tendon, muscle, and bone. However, research has shown that sheep rotator cuff muscle undergoes similar chronic degradation, including muscle fatty infiltration and fibrosis, in situations of acute repair. 5, 23 Regardless, we realize a limitation of this study is that the results have not been assessed for human clinical benefit in a large human patient population. Future studies in large patient populations would ultimately be needed to determine the device's effectiveness in terms of outcomes and quality of life postoperation.
There is a clear need for improving rotator cuff repair strategies based on the high repair failure rates in patients. 1, 11, 13 Scaffold devices, derived from mammalian extracellular matrix (EM) and/or synthetic polymers, are becoming increasingly popular to potentially enhance the intrinsic healing potential of the tendon. 2, 8, 30 Many serve to mechanically ''off-load'' the repair in the early healing phases by increasing the tendon-bone contact, while others serve to biologically improve the rate and quality of healing. The overarching goal of all devices is to improve the quality and speed of healing. A scaffold, like the one used in this study, that would serve to enhance biological healing without requiring additional surgical steps or the implantation of additional devices would be appealing and have a potentially positive impact in rotator cuff repair outcomes.
Conclusion
Use of a vented anchor attached to a bioresorbable interpositional scaffold composed of aligned PLGA microfibers improves the histologic properties of rotator cuff repair in a sheep model. Improved histology is correlated with improved final construct strength. Use of a vented anchor in combination with an interpositional PLGA scaffold may improve tendon healing and strength for rotator cuff repair. Future clinical studies are needed to confirm these improved healing properties in the human population. 
